Chitraka (Plumbago zeylanica): Uses, Evidence and Safety

Plumbago zeylanica Chitraka plant with white flowers and root used in traditional herbal medicine

If you come across Chitraka in an Ayurvedic text, herbal formulation or discussion of medicinal plants, it is worth asking a basic question before assuming that it is simply another everyday herb: what exactly is known about the plant, and what evidence supports its medicinal use?

Chitraka is commonly associated with Plumbago zeylanica, a plant in the Plumbaginaceae family. Its root has a longstanding place in Ayurvedic medicine, while modern researchers have investigated compounds from the plant—particularly plumbagin—for a range of biological activities.

Those two bodies of information should not be confused.

Traditional use can tell us how a plant has been used within a medical tradition. Laboratory research can show how an isolated compound behaves in cells or experimental models. Neither, on its own, demonstrates that taking a particular Chitraka preparation safely treats a disease.

Identifying the plant correctly

Kew's Plants of the World Online currently accepts Plumbago zeylanica L. as a botanical species in the Plumbaginaceae family. Its native range extends across tropical and subtropical regions, including parts of India. Plants of the World Online

Correct identification matters because the name "Chitraka" is used in traditional medicine, while the genus Plumbago contains multiple species. A scientific study involving authenticated P. zeylanica cannot automatically be applied to an unidentified herbal powder or another Plumbago species.

For that reason, a useful Chitraka discussion should distinguish:

  • the botanical species;
  • the plant part being studied;
  • the type of preparation;
  • the chemical constituents being investigated; and
  • the evidence available for humans.

These distinctions become particularly important when safety is considered.

Chitraka in Ayurveda

Chitraka has a longstanding role in Ayurvedic medicine, especially in traditional formulations associated with digestion and appetite.

The Ayurvedic concept of Agni, for example, belongs to the explanatory framework of Ayurveda. It should not automatically be translated into a modern biomedical statement such as "increases stomach acid," "boosts metabolism," or "treats indigestion."

A respectful description of traditional medicine does not require treating its concepts as equivalent to modern physiology.

It is reasonable to say that Chitraka has been used traditionally for particular purposes. It is not reasonable to turn that history into proof that Chitraka treats a diagnosed gastrointestinal disease.

Why researchers study plumbagin

One reason P. zeylanica attracts scientific interest is plumbagin, a naturally occurring naphthoquinone found in Plumbago species.

Researchers have investigated plumbagin in areas including cellular signaling, oxidative stress, inflammation, antimicrobial activity and cancer biology. Reviews describe substantial preclinical interest but also emphasize problems such as poor bioavailability and toxicity that complicate development as a therapeutic compound. PubMed

This distinction is crucial:

Chitraka is a plant. Plumbagin is one chemical constituent of the plant.

A study using purified plumbagin is therefore not automatically a study of an Ayurvedic Chitraka preparation.

The concentration and chemical profile can differ between plant material, extracts and formulations. Consequently, findings involving isolated plumbagin should not be presented as though they were clinical evidence for consuming Chitraka.

What the research can—and cannot—tell us

Antimicrobial research

Plumbagin and Plumbago preparations have been investigated for antimicrobial activity, including laboratory research involving bacteria.

Such findings can help researchers investigate possible mechanisms or identify compounds for future drug development.

They do not establish that taking Chitraka treats a bacterial infection.

A compound that affects bacteria in a laboratory has to pass several additional stages of research before it can be considered an appropriate human treatment. Researchers need to establish effective exposure, safety, pharmacokinetics, dosing and clinical benefit.

Chitraka should therefore not be used as a substitute for antibiotics or other prescribed treatment on the basis of laboratory antimicrobial findings.

Inflammation and other biological effects

Experimental studies have investigated plumbagin and Plumbago preparations for effects related to inflammatory and other biological pathways.

These findings are scientifically relevant but remain different from evidence that a whole-plant preparation produces a meaningful clinical benefit in people.

The safer interpretation is:

Research has investigated biological effects of plumbagin and Plumbago preparations; this does not establish a clinically effective Chitraka treatment.

Cancer research

Plumbagin has received considerable attention in cancer research because laboratory and animal studies have reported effects involving apoptosis, cell-cycle regulation, oxidative stress and other cellular pathways. PubMed

This is an area where online health information can easily become misleading.

A compound producing effects in cancer cells is not the same as a proven cancer treatment.

There is a substantial difference between:

  • a laboratory experiment involving cancer cells;
  • an animal study;
  • a human clinical trial of a defined compound; and
  • taking a traditional whole-plant preparation.

The current research does not justify telling people to use Chitraka for cancer or to modify established cancer treatment.

Metabolic research

Plumbagin and related preparations have also been investigated experimentally for metabolic effects.

Such research may be useful for understanding biological pathways and potential drug-development targets. It should not, however, be converted into claims that Chitraka is a weight-loss treatment or a treatment for diabetes.

A biological effect observed in an experimental model does not automatically translate into a clinically meaningful effect in humans.

The important evidence gap

The central issue with Chitraka is not that researchers have found nothing interesting.

They have.

The issue is what those findings demonstrate in humans.

For a botanical preparation to be established as a treatment for a particular condition, researchers need appropriate human evidence involving a defined preparation and clinically meaningful outcomes.

Important questions include:

  • What exact preparation was used?
  • Which plant part was used?
  • Was the species authenticated?
  • What were the active constituents?
  • Was the preparation standardized?
  • How much was administered?
  • How many people were studied?
  • Was there a suitable comparison group?
  • What benefits were measured?
  • What adverse effects occurred?

Without this information, promising laboratory research should remain classified as preliminary rather than presented as established treatment evidence.

Why the preparation matters

"Chitraka" does not necessarily describe one chemically identical product.

The characteristics of a botanical preparation can vary with:

  • species and plant identity;
  • plant part;
  • cultivation and harvesting;
  • storage;
  • extraction method;
  • processing;
  • concentration;
  • contamination or adulteration.

This is particularly important when research uses a defined extract or purified compound.

The result from an experimental preparation cannot automatically be assumed to apply to an unidentified herbal product.

NCCIH also emphasizes that herbal and botanical products can differ in composition and can have pharmacological effects, interactions and contamination-related safety concerns. NCCIH

What about Ayurvedic Shodhana?

Ayurvedic sources describe processing procedures for Chitraka before medicinal use.

Modern research has begun examining what happens chemically during such processing. A 2024/2025 study of P. zeylanica reported that an Ayurvedic shodhana process reduced plumbagin content and altered several constituents. PubMed

Another published study specifically investigated purification procedures for Chitraka and its plumbagin content. PubMed

These studies are useful because they show that processing can change the chemical characteristics of botanical material.

But there is an important limitation:

A laboratory finding that a processing method changes chemical composition is not the same as clinical evidence that every traditionally processed Chitraka product is safe.

Readers should therefore not attempt to reproduce medicinal processing procedures at home or assume that the word "purified" guarantees safety.

Is medicinal Chitraka safe?

It would be inaccurate to describe medicinal Chitraka as automatically safe simply because it is a plant.

Preclinical studies have identified toxicological concerns. For example, a study comparing different P. zeylanica root extracts in rats found substantial differences in toxicity between extracts and reported changes in several laboratory and organ-related measures. The authors also found a relationship between extract toxicity and plumbagin content. PubMed

A separate animal study of a P. zeylanica root extract used topically found moderate skin irritation under the experimental conditions. PubMed

These studies do not establish that a particular human exposure will cause the same effects. They do establish why medicinal Chitraka deserves more caution than an ordinary culinary ingredient.

The practical conclusion is therefore not "Chitraka is always toxic."

It is:

The safety of medicinal Chitraka depends on the actual preparation, exposure and individual circumstances, and available evidence is not strong enough to treat it as a routine daily wellness supplement.

Natural does not mean risk-free

The fact that an ingredient comes from a plant does not establish that it is:

  • safe at every dose;
  • suitable for everyone;
  • free of pharmacological effects;
  • compatible with medicines; or
  • appropriate during pregnancy.

NCCIH notes that herbal products can interact with medicines and that some interaction concerns are based on limited or indirect evidence. Extra caution is warranted with medicines for which relatively small changes in drug exposure can have serious consequences. NCCIH

That is a better way to think about Chitraka than simply asking whether it is "natural."

Who should avoid self-experimentation?

Because human evidence for medicinal Chitraka is limited, self-directed use deserves particular caution in situations where adverse effects could have greater consequences.

Pregnancy and breastfeeding

There is insufficient evidence to assume that medicinal Chitraka is safe during pregnancy or breastfeeding.

Anyone considering an herbal medicinal preparation during these periods should discuss the specific product with an appropriately qualified healthcare professional.

Children

Adult herbal practices should not simply be transferred to children.

Do not give medicinal Chitraka to a child based on an adult dose or advice found online.

Chronic health conditions

People with significant chronic health conditions should discuss medicinal herbal products with a healthcare professional, particularly when the product is concentrated or used regularly.

Prescription medicines

Tell your doctor or pharmacist about herbal products you take.

This does not mean that every proposed herb–drug interaction is proven. In fact, NCCIH notes that many interaction claims are based on animal studies, laboratory studies or other indirect evidence. NCCIH

The point is that uncertainty itself can be important when a person is taking medication.

What should you do if you feel unwell after using it?

Do not try to treat a suspected adverse reaction with another home remedy.

Seek medical advice for significant or worsening symptoms, particularly:

  • difficulty breathing;
  • swelling of the face, lips or throat;
  • severe or persistent vomiting;
  • severe abdominal pain;
  • marked dizziness or weakness;
  • confusion;
  • extensive skin reactions; or
  • other severe or rapidly worsening symptoms.

If an herbal product may have been taken in excessive quantity, keep its packaging or ingredient information available for healthcare professionals.

How to evaluate a Chitraka claim online

When you encounter a claim about Chitraka, ask six simple questions.

What exactly was studied?
Was it the whole plant, root, extract, traditional formulation or purified plumbagin?

Was the research conducted in humans?
Cell and animal research can be valuable, but it does not establish human treatment effectiveness.

Was the preparation comparable?
An experimental extract may not resemble an unidentified herbal powder.

Were adverse effects measured?
Evidence about possible benefits is incomplete without consideration of harms.

Is traditional use being presented as traditional use?
A historical Ayurvedic indication should not quietly become a modern disease-treatment claim.

Is the headline stronger than the study?
Terms such as "cures," "reverses," "detoxifies," "melts fat" or "kills cancer" should prompt careful examination of the underlying evidence.

What can reasonably be concluded?

Several points can be stated with reasonable confidence.

Plumbago zeylanica is an accepted botanical species associated with the traditional medicinal plant Chitraka. Plants of the World Online

Chitraka has a longstanding place in Ayurvedic medicine, including traditional digestive applications.

The plant contains biologically active constituents including plumbagin, which has been extensively investigated experimentally.

Research into plumbagin includes antimicrobial, inflammatory, metabolic and cancer-related biological questions, but much of this evidence remains preclinical. Reviews continue to identify issues involving bioavailability and toxicity and the need for further clinical investigation. PubMed

Processing can alter the chemical profile of Chitraka, but this should not be interpreted as proof that every processed preparation is clinically safe. PubMed

Most importantly, laboratory research on plumbagin should not be presented as proof that taking Chitraka safely treats a disease.

A sensible way to approach Chitraka

For readers interested in Ayurveda or medicinal plants, Chitraka is a worthwhile subject to study from botanical, historical and pharmacological perspectives.

If the question is whether to take a medicinal Chitraka preparation, however, the relevant question is much more specific:

What exact preparation is being considered, and what evidence and safety information exist for that preparation?

That is especially important for concentrated extracts, medicinal formulations and products taken regularly.

Traditional knowledge can be studied respectfully without presenting it as clinical proof. Scientific research can be discussed enthusiastically without turning laboratory findings into treatment promises.

That distinction is what makes information about medicinal plants genuinely useful.

Medical Disclaimer

This article is for general educational purposes. It does not provide individualized medical advice, diagnosis, dosage instructions or a treatment protocol. Traditional use does not establish clinical effectiveness, and laboratory or animal research should not be interpreted as proof that Chitraka treats a disease. If you are considering medicinal use of a Chitraka preparation, discuss the specific product and your circumstances with an appropriately qualified healthcare professional or pharmacist. Do not use Chitraka to replace or delay prescribed treatment.

Related Articles: 

Plumbago zeylanica is one of many plants discussed in traditional Ayurvedic practice. For a broader overview of medicinal herbs, see our guide to Ayurvedic medicinal herbs.

If you are interested in how different plant parts are traditionally used in Ayurveda, explore our guide to Ayurvedic leaves, flowers and bark.

Some medicinal plants require particular caution because traditional use does not necessarily establish modern safety. For another example, see our guide to Datura leaf use and safety considerations.

External Resources: 

For scientific information about plumbagin, its potential biological effects and toxicity, see this PubMed review of plumbagin derivatives, bioavailability and toxicity.

For research on the traditional Ayurvedic processing of Plumbago zeylanica and its effect on plumbagin content, see this PubMed study on the chemical basis of Plumbago zeylanica detoxification.

No comments: